TickrTrends STE fair value analysis

STERIS Announces Financial Results for Fiscal 2027 Second Quarter

manilatimes.net · 2026-11-04

Fiscal 2027 second quarter revenue increased 9%; constant currency organic revenue growth was 8% Fiscal 2027 second quarter as reported diluted EPS increased to $2.19; adjusted EPS per diluted share increased to $2.94Outlook updated to reflect solid underlying performance and the benefit of tariff refunds DUBLIN, IRELAND, Nov. 04, 2026 (GLOBE NEWSWIRE) -- STERIS plc (NYSE: STE) ('STERIS” or the 'Company”) today announced financial results for its fiscal 2027 second quarter ended September 30, 2026. Total revenue for the second quarter of fiscal 2027 increased 9% to $1.6 billion compared with $1.5 billion in the second quarter of fiscal 2026. Constant currency organic revenue growth was 8% in the second quarter.

TickrTrends take: STERIS operates in the Healthcare sector where STERIS has been flagged as undervalued according to TickrTrends' current assessment. The fiscal 2027 second quarter results provide an opportunity to evaluate whether the company's operational performance supports or challenges this valuation view. Investors focused on valuation metrics should monitor how the quarter's financial outcomes align with the company's current market pricing.

Read the full story at manilatimes.net →

Is STE undervalued? See TickrTrends' fair value analysis →